This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Mar;9(3):134.

doi: 10.1038/nrendo.2013.13. Epub 2013 Jan 29.

Bone: zoledronic acid-interdose interval of >1 year effective?

PMID: 23358364
DOI: 10.1038/nrendo.2013.13

Comment

Bone: zoledronic acid-interdose interval of >1 year effective?

Carol Wilson. Nat Rev Endocrinol. 2013 Mar.

. 2013 Mar;9(3):134.

doi: 10.1038/nrendo.2013.13. Epub 2013 Jan 29.

Author

PMID: 23358364
DOI: 10.1038/nrendo.2013.13

No abstract available

PubMed Disclaimer

Comment on

Reduction in the risk of clinical fractures after a single dose of zoledronic Acid 5 milligrams.
Reid IR, Black DM, Eastell R, Bucci-Rechtweg C, Su G, Hue TF, Mesenbrink P, Lyles KW, Boonen S; HORIZON Pivotal Fracture Trial and HORIZON Recurrent Fracture Trial Steering Committees. Reid IR, et al. J Clin Endocrinol Metab. 2013 Feb;98(2):557-63. doi: 10.1210/jc.2012-2868. Epub 2013 Jan 4. J Clin Endocrinol Metab. 2013. PMID: 23293335 Clinical Trial.

References

1. J Clin Endocrinol Metab. 2013 Feb;98(2):557-63 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations